Coronavirus: dermatology update
In response to the coronavirus (COVID-19) outbreak, please read our advice and information.
Clinical research in this area includes the identification of new allergens and studies looking at the epidemiology of contact allergy. Data from our studies are fed into European institutions to influence the control and elimination of allergens on the consumer market.
Recent projects include evaluation of the impact of isothiazolinone contact allergy in Europe and demonstrating the importance of aromatic substance allergy on eczema and quality of life.
Find out more about our open and completed clinical trials.